Compare · EW vs OFLX
EW vs OFLX
Side-by-side comparison of Edwards Lifesciences Corporation (EW) and Omega Flex Inc. (OFLX): market cap, price performance, sector, and recent activity on the wire.
Summary
- EW operates in Health Care, while OFLX operates in Industrials - the two are in different parts of the market.
- EW is the larger of the two at $48.52B, about 140.1x OFLX ($346.3M).
- Over the past year, EW is up 11.4% and OFLX is up 8.9% - EW leads by 2.5 points.
- EW has hit the wire 5 times in the past 4 weeks while OFLX has been quiet.
- EW has more recent analyst coverage (25 ratings vs 0 for OFLX).
- Company
- Edwards Lifesciences Corporation
- Omega Flex Inc.
- Price
- $84.16+5.54%
- $33.93+1.47%
- Market cap
- $48.52B
- $346.3M
- 1M return
- +1.83%
- +12.99%
- 1Y return
- +11.37%
- +8.87%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 5
- 0
- Recent ratings
- 25
- 0
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Omega Flex Inc.
Omega Flex, Inc., together with its subsidiaries, manufactures and sells flexible metal hoses and accessories in the United States and internationally. It offers flexible gas piping for use in residential and commercial buildings, as well as its fittings; and corrugated medical tubing for use in hospitals, ambulatory care centers, dental, physician and veterinary clinics, laboratories, and other facilities. The company sells its products under the TracPipe, CounterStrike, AutoSnap, AutoFlare, DoubleTrac, DEF-Trac, and MediTrac brand names. It serves various markets, including construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. The company sells its products through independent sales representatives, distributors, original equipment manufacturers, and direct sales, as well as through its website. The company was formerly known as Tofle America, Inc. and changed its name to Omega Flex, Inc. in 1996. Omega Flex, Inc. was incorporated in 1975 and is based in Exton, Pennsylvania.
Latest EW
- Edwards Lifesciences Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Edwards Lifesciences Reports First Quarter Results
- Edwards Lifesciences to Host Earnings Conference Call on April 23, 2026
- SEC Form 4 filed by Ullem Scott B.
- SEC Form 4 filed by Lippis Daniel J.
- SEC Form 4 filed by Bobo Donald E Jr
- Edwards Lifesciences upgraded by Wolfe Research with a new price target
- Two Year Data on Edwards Lifesciences' EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits
- Amendment: SEC Form SCHEDULE 13G/A filed by Edwards Lifesciences Corporation
- SEC Form DEFA14A filed by Edwards Lifesciences Corporation
Latest OFLX
- Omega Flex, Inc. Announces Regular Quarterly Dividend for the First Quarter 2026
- Omega Flex Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Chief Executive Officer Rivest Dean W. bought $29,500 worth of shares (1,000 units at $29.50) (SEC Form 4)
- SEC Form 10-K filed by Omega Flex Inc.
- Omega Flex, Inc. Announces Fourth Quarter 2025 Earnings
- Omega Flex Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Vice President - CFO Unger Matthew Francis converted options into 395 shares and returned $14,832 worth of shares to the company (395 units at $37.55) (SEC Form 4)
- President Moran Edwin B. returned $18,550 worth of shares to the company (494 units at $37.55) and converted options into 494 shares (SEC Form 4)
- Chief Executive Officer Rivest Dean W. converted options into 593 shares and returned $22,267 worth of shares to the company (593 units at $37.55) (SEC Form 4)
- SEC Form 4 filed by VP, General Counsel, Secretary Asch Susan B.